abstract |
Disclosed are compounds of formula (I) useful for treating various diseases and disorders mediated or sustained through the activity of CCR1, including autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The Methods of making and using the methods are also disclosed. [Chemical 1] (I) |